RetinalGenix Technologies (RTGN) Current Leases (2024 - 2026)

RetinalGenix Technologies' (RTGN) quarterly Current Leases came in at $2860.0 in Q1 2026, up 189.47% year-on-year from $988.0 in Q1 2025, and little changed quarter-over-quarter from $2860.0 in Q4 2025.

RetinalGenix Technologies (RTGN) Current Leases (2024 - 2026) Analysis & Trends

RetinalGenix Technologies has disclosed Current Leases across 3 years of filings, most recently posting $2860.0 for Q1 2026.

  • Current Leases for Q1 2026 came in at $2860.0, up 189.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $2860.0 (up 189.47% YoY), and the FY2025 annual result was $2860.0, up 189.47% from the prior year.
  • Current Leases came in at $2860.0 for Q1 2026 at RetinalGenix Technologies, roughly flat from $2860.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2860.0 in Q4 2025 to a low of $662.0 in Q3 2024.
  • The 3-year median for Current Leases is $988.0 (2024), against an average of $1476.3.
  • Peak annual rise in Current Leases reached 189.47% in 2025, while the deepest fall reached 49.24% in 2025.
  • RetinalGenix Technologies' Current Leases stood at $988.0 in 2024, then surged by 189.47% to $2860.0 in 2025, then changed by 0.0% to $2860.0 in 2026.
  • The last three Current Leases figures came in at $2860.0 (Q1 2026), $2860.0 (Q4 2025), and $988.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 24.30 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 20.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 35.80 Mn
10 RetinalGenix Technologies - - - 2,860.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2,860.00
Dec 31, 2025 2,860.00
Sep 30, 2025 988.00
Jun 30, 2025 988.00
Mar 31, 2025 988.00
Dec 31, 2024 988.00
Sep 30, 2024 662.00